GSK1349572 + Placebo + Iohexol Injection + Para-aminohippurate infusion
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Infections, Human Immunodeficiency Virus and Tuberculosis
Conditions
Infections, Human Immunodeficiency Virus and Tuberculosis
Trial Timeline
Oct 1, 2010 → Nov 1, 2010
NCT ID
NCT01214993About GSK1349572 + Placebo + Iohexol Injection + Para-aminohippurate infusion
GSK1349572 + Placebo + Iohexol Injection + Para-aminohippurate infusion is a phase 1 stage product being developed by Shionogi for Infections, Human Immunodeficiency Virus and Tuberculosis. The current trial status is completed. This product is registered under clinical trial identifier NCT01214993. Target conditions include Infections, Human Immunodeficiency Virus and Tuberculosis.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01214993 | Phase 1 | Completed |
Competing Products
20 competing products in Infections, Human Immunodeficiency Virus and Tuberculosis